Privately-held BDD Pharma said today that it signed a deal to license its OralogiK timed drug-delivery tech to Novartis (NYSE:NVS). Financial details of the agreement were not disclosed, but BDD noted that it included an upfront payment, milestones and future royalties. BDD’s technology can deliver multiple doses or a combination of drugs at pre-determined times, between […]
